- |||||||||| YUVA-GT-F801 / SZGIMI
Phase classification, Trial completion date, Trial primary completion date, Gene therapy: Lentiviral FVIII Gene Therapy (clinicaltrials.gov) - May 23, 2019
P1, N=10, Not yet recruiting,
Phase classification: P1/2 --> P1 | Trial completion date: Dec 2021 --> Jun 2022 | Trial primary completion date: Dec 2020 --> May 2022
- |||||||||| YUVA-GT-F801 / SZGIMI
Trial completion date, Trial primary completion date, Gene therapy: Lentiviral FVIII Gene Therapy (clinicaltrials.gov) - Feb 19, 2018
P1/2, N=10, Enrolling by invitation,
Phase classification: P1/2 --> P1 | Trial completion date: Dec 2021 --> Jun 2022 | Trial primary completion date: Dec 2020 --> May 2022 Trial primary completion date: Dec 2019 --> Dec 2020 | Trial completion date: Dec 2020 --> Dec 2021
- |||||||||| YUVA-GT-F801 / SZGIMI
Enrollment open, Gene therapy: Lentiviral FVIII Gene Therapy (clinicaltrials.gov) - Jul 19, 2017
P1/2, N=10, Enrolling by invitation,
Trial primary completion date: Dec 2019 --> Dec 2020 | Trial completion date: Dec 2020 --> Dec 2021 Not yet recruiting --> Enrolling by invitation
- |||||||||| YUVA-GT-F801 / SZGIMI
New P1/2 trial, Gene therapy: Lentiviral FVIII Gene Therapy (clinicaltrials.gov) - Jul 12, 2017
P1/2, N=10, Not yet recruiting,
|
